Influences of Atorvastatin in different doses on atherogenic index of plasma and outcomes in patients with acute myocardial infarction
BAO Feng-mei
MA Wei-li
ZHANG Li-li
Abstract:Objective To investigate the influences of Atorvastatin on atherogenic index of plasma and (AIP) and major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI).Methods A total of 212 patients diagnosed as AMI in our department were randomly divided into two groups:the standard group (n=106) and the intensive group (n=106).Both group patients were given basic treatment of AMI.Patients in the standard group were given Atorvastatin (20 mg/d) and patients in the intensive group were given Atorvastatin(40 mg/d).Blood lipid,AIP and pulse wave velocity(PWV) were evaluated after 1 years' therapy.At the same time,the incidence of MACE were recorded.Results Relation analysis showed that AIP level was positively correlated with PWV (r=0.801,P<0.05).After 1 years' treatment,the AIP were decreased in both group patients[before treatment (0.34±0.06) vs after treatment (0.22±0.05),P<0.05] and [before treatment (0.33±0.06) vs after treatment(0.17±0.05),P<0.05],and the changes were more marked in intensive group [at standard group (0.22±0.05) vs at intensive group (0.17±0.05),P<0.05].The intima-media thickness in the intensive treatment group was significantly lower than that before treatment [before treatment (1.41 ±0.18)mm vs after treatment (1.10± 0.17)mm,P<0.05].After 1 years' treatment,the incidence of MACE was lower in intensive group than that in standard group (at standard group 22.64% vs at intensive group 11.32%,P<0.05) Conclusion The intensive treatment of Atorvastatin can significantly reduced AIP levels and MACE in the patients with AMI.
Keywords:Acute myocardial infarctionAtherosclerosisAtherogenic index of plasmaPulse wave velocityMajor adverse cardiovascular events
Publication Date:2017-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:5( 945-949 )
Chinese Journal of Cardiovascular Research

Chinese Journal of Cardiovascular Research

ISTIC
ISSN:1672-5301
Year, Vol.(Issue):2017,15(10)